Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR-T Cell Recipients-PART 2: Antiviral Therapy and Virus-Specific T Cell Therapy for HCMV in Allo-HSCT.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41914212

Allison Abendroth; Barry Slobedman; Danya Kaplan; David J Gottlieb; Emily Blyth; Gaurav Sutrave; Lauren Stern; Michelle K Yong

Apr 1, 2026